Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Dae Seog Heo's publication output changed over time?
ScholarIQpublication output · 1993–2017
Output grew0% over the shown period — from 1 works in 1993 to 1 in 2017.
1
3
1
1
1
2
2
1
19932004200520062011201220162017
What are the most-cited papers on Dae Seog Heo?
ScholarIQmost cited works
Afatinib versus placebo for patients with advanced, metastatic non-small-cell lung cancer after failure of erlotinib, gefitinib, or both, and one or two lines of chemotherapy (LUX-Lung 1): a phase 2b/3 randomised trial
Vincent A. Miller, Vera Hirsh, Jacques Cadranel, Yuh-Min Chen, Keunchil Park, Sang-We Kim, Caicun Zhou, Wu‐Chou Su, Mengzhao Wang, Yan Sun, Dae Seog Heo, Lucio Crinò, Eng-Huat Tan, Tsu-Yi Chao, Mehdi Shahidi, Xiuyu Julie Cong, Robert M. Lorence, James Chih‐Hsin Yang
The Lancet Oncology. 2012957 Citations
Phase I and Pharmacokinetic Study of Genexol-PM, a Cremophor-Free, Polymeric Micelle-Formulated Paclitaxel, in Patients with Advanced Malignancies
Tae‐You Kim, Dong-Wan Kim, Jae‐Yong Chung, Sang Goo Shin, Sungchul Kim, Dae Seog Heo, Noe Kyeong Kim, Yung‐Jue Bang
Clinical Cancer Research. 2004807 Citations
Predictive and Prognostic Impact of Epidermal Growth Factor Receptor Mutation in Non–Small-Cell Lung Cancer Patients Treated With Gefitinib
Sae‐Won Han, Tae‐You Kim, Pil Gyu Hwang, Soohyun Jeong, Jeongmi Kim, In Sil Choi, Do‐Youn Oh, Jee Hyun Kim, Dong‐Wan Kim, Doo Hyun Chung, Seock‐Ah Im, Young Tae Kim, Jong Seok Lee, Dae Seog Heo, Yung‐Jue Bang, Noe Kyeong Kim
Journal of Clinical Oncology. 2005775 CitationsOPEN ACCESS
Elevated TGF-β1 Secretion and Down-Modulation of NKG2D Underlies Impaired NK Cytotoxicity in Cancer Patients
June-Chul Lee, Kyung‐Mi Lee, Dong‐Wan Kim, Dae Seog Heo
S38008053. 2004540 CitationsOPEN ACCESS
Clonal History and Genetic Predictors of Transformation Into Small-Cell Carcinomas From Lung Adenocarcinomas
Jake June-Koo Lee, Junehawk Lee, Sehui Kim, Soyeon Kim, Jeonghwan Youk, Seongyeol Park, Yohan An, Bhumsuk Keam, Dong‐Wan Kim, Dae Seog Heo, Young Tae Kim, Jin-Soo Kim, Se Hyun Kim, Jong Seok Lee, Se‐Hoon Lee, Keunchil Park, Ja‐Lok Ku, Yoon Kyung Jeon, Doo Hyun Chung, Peter J. Park, Joon Kim, Tae‐Min Kim, Young Seok Ju
Journal of Clinical Oncology. 2017515 Citations
Related on ScholarIQ
Seoul National University
Institution
Afatinib versus placebo for patients with advanced, metastatic non-small-cell lung cancer after failure of erlotinib, gefitinib, or both, and one or two lines of chemotherapy (LUX-Lung 1): a phase 2b/3 randomised trial
Paper
Phase I and Pharmacokinetic Study of Genexol-PM, a Cremophor-Free, Polymeric Micelle-Formulated Paclitaxel, in Patients with Advanced Malignancies
Paper
Predictive and Prognostic Impact of Epidermal Growth Factor Receptor Mutation in Non–Small-Cell Lung Cancer Patients Treated With Gefitinib
Paper
Elevated TGF-β1 Secretion and Down-Modulation of NKG2D Underlies Impaired NK Cytotoxicity in Cancer Patients
Paper
Clonal History and Genetic Predictors of Transformation Into Small-Cell Carcinomas From Lung Adenocarcinomas
Paper